uuid stringlengths 4 8 | template_uuid stringclasses 40
values | question stringlengths 13 193 | answer stringlengths 29 2.2k | benchmark_query stringlengths 133 622 | execution_results stringlengths 2 1.14M | query_type stringclasses 2
values | sql_category stringclasses 26
values | bio_category stringclasses 14
values |
|---|---|---|---|---|---|---|---|---|
Q59.1159 | Q59 | What is the genetic target of the small molecule drug Suprofen, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Suprofen: PTGS2 and PTGS1. Suprofen reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%suprofen%" OR LOWER(tradeNames_string) LIKE "%suprofen%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_792', 'drugName': 'Suprofen', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756), PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 1985, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.39 | Q59 | What is the genetic target of the small molecule drug Aripiprazole Lauroxil, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Aripiprazole Lauroxil: DRD2, HTR2A, and HTR1A. Aripiprazole Lauroxil reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%aripiprazole lauroxil%" OR LOWER(tradeNames_string) LIKE "%aripipraz... | [{'UUID': 'DrugGeneTargets_v2_4679', 'drugName': 'Aripiprazole Lauroxil', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295), HTR2A (ENSG00000102468), HTR1A (ENSG00000178394)', 'yearOfFirstApproval': 2015, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTarg... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.720 | Q59 | What is the genetic target of the small molecule drug Ergotamine Tartrate, and what is its status in clinical trials and FDA approval? | There are 7 genetic targets of the small molecule drug Ergotamine Tartrate: ADRA1A, ADRA2A, ADRA2C, ADRA1D, ADRA1B, ADRA2B, and HTR1D. Ergotamine Tartrate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ergotamine tartrate%" OR LOWER(tradeNames_string) LIKE "%ergotamine ... | [{'UUID': 'DrugGeneTargets_v2_3552', 'drugName': 'Ergotamine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HTR1D (ENSG00000179546), ADRA1A (ENSG00000120907), ADRA2A (ENSG00000150594), ADRA2C (ENSG00000184160), ADRA1D (ENSG00000171873), ADRA1B (ENSG00000170214), ADRA2B (ENSG00000274286)', 'yearOfF... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.93 | Q59 | What is the genetic target of the small molecule drug Bezafibrate, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Bezafibrate: PPARG, PPARA, and PPARD. Bezafibrate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%bezafibrate%" OR LOWER(tradeNames_string) LIKE "%bezafibrate%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_1564', 'drugName': 'Bezafibrate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PPARG (ENSG00000132170), PPARA (ENSG00000186951), PPARD (ENSG00000112033)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1937 | Q59 | What is the genetic target of the antibody drug Eculizumab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Eculizumab is C5. Eculizumab reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%eculizumab%" OR LOWER(tradeNames_string) LIKE "%eculizumab%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_844', 'drugName': 'Eculizumab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'C5 (ENSG00000106804)', 'yearOfFirstApproval': 2007, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1215 | Q59 | What is the genetic target of the small molecule drug Bismuth Subgallate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Bismuth Subgallate is F12. Bismuth Subgallate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%bismuth subgallate%" OR LOWER(tradeNames_string) LIKE "%bismuth subg... | [{'UUID': 'DrugGeneTargets_v2_5123', 'drugName': 'Bismuth Subgallate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'F12 (ENSG00000131187)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.882 | Q59 | What is the genetic target of the small molecule drug Ubrogepant, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ubrogepant is CALCRL. Ubrogepant reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ubrogepant%" OR LOWER(tradeNames_string) LIKE "%ubrogepant%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_528', 'drugName': 'Ubrogepant', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CALCRL (ENSG00000064989)', 'yearOfFirstApproval': 2019, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1353 | Q59 | What is the genetic target of the small molecule drug Allopurinol Sodium, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Allopurinol Sodium is XDH. Allopurinol Sodium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%allopurinol sodium%" OR LOWER(tradeNames_string) LIKE "%allopurinol ... | [{'UUID': 'DrugGeneTargets_v2_3457', 'drugName': 'Allopurinol Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'XDH (ENSG00000158125)', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1891 | Q59 | What is the genetic target of the antibody drug Az9773, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Az9773 is TNF. Az9773 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%az9773%" OR LOWER(tradeNames_string) LIKE "%az9773%" OR LOWER(drugSy... | [{'UUID': 'DrugGeneTargets_v2_3954', 'drugName': 'Az9773', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'TNF (ENSG00000232810)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1102 | Q59 | What is the genetic target of the small molecule drug Bms-754807, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Bms-754807: IGF1R and INSR. Bms-754807 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%bms-754807%" OR LOWER(tradeNames_string) LIKE "%bms-754807%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_1288', 'drugName': 'Bms-754807', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'IGF1R (ENSG00000140443), INSR (ENSG00000171105)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_1289', 'drugName': 'Bms-754807'... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1165 | Q59 | What is the genetic target of the antibody drug Imc-Eb10, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Imc-Eb10 is FLT3. Imc-Eb10 reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%imc-eb10%" OR LOWER(tradeNames_string) LIKE "%imc-eb10%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_1054', 'drugName': 'Imc-Eb10', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'FLT3 (ENSG00000122025)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1365 | Q59 | What is the genetic target of the small molecule drug Almotriptan, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Almotriptan: HTR1F, HTR1D, and HTR1B. Almotriptan reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%almotriptan%" OR LOWER(tradeNames_string) LIKE "%almotriptan%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3460', 'drugName': 'Almotriptan Malate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HTR1F (ENSG00000179097), HTR1D (ENSG00000179546), HTR1B (ENSG00000135312)', 'yearOfFirstApproval': 2001, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTarget... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1959 | Q59 | What is the genetic target of the small molecule drug Deslanoside, and what is its status in clinical trials and FDA approval? | There are 8 genetic targets of the small molecule drug Deslanoside: ATP1A1, ATP1B2, ATP1B1, ATP1A2, ATP1B3, ATP1A3, ATP1A4, and FXYD2. Deslanoside reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%deslanoside%" OR LOWER(tradeNames_string) LIKE "%deslanoside%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_1509', 'drugName': 'Deslanoside', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ATP1A1 (ENSG00000163399), ATP1B2 (ENSG00000129244), ATP1B1 (ENSG00000143153), ATP1A2 (ENSG00000018625), ATP1B3 (ENSG00000069849), ATP1A3 (ENSG00000105409), ATP1A4 (ENSG00000132681), FXYD2 (... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.505 | Q59 | What is the genetic target of the small molecule drug Ttp-607, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Ttp-607: AURKB, AURKC, and AURKA. Ttp-607 reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ttp-607%" OR LOWER(tradeNames_string) LIKE "%ttp-607%" OR LOWER(drug... | [{'UUID': 'DrugGeneTargets_v2_4902', 'drugName': 'Ttp-607', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'AURKB (ENSG00000178999), AURKC (ENSG00000105146), AURKA (ENSG00000087586)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.342 | Q59 | What is the genetic target of the small molecule drug Encorafenib, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Encorafenib is BRAF. Encorafenib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%encorafenib%" OR LOWER(tradeNames_string) LIKE "%encorafenib%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3616', 'drugName': 'Encorafenib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'BRAF (ENSG00000157764)', 'yearOfFirstApproval': 2018, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1198 | Q59 | What is the genetic target of the small molecule drug Clidinium Bromide, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Clidinium Bromide: CHRM3 and CHRM1. Clidinium Bromide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%clidinium bromide%" OR LOWER(tradeNames_string) LIKE "%clidinium bro... | [{'UUID': 'DrugGeneTargets_v2_5459', 'drugName': 'Umeclidinium Bromide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM3 (ENSG00000133019)', 'yearOfFirstApproval': 2013, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6136', 'drugName': 'Aclidinium Bromide', 'd... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.29 | Q59 | What is the genetic target of the small molecule drug Prednisolone Phosphoric Acid, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Prednisolone Phosphoric Acid is NR3C1. Prednisolone Phosphoric Acid reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%prednisolone phosphoric acid%" OR LOWER(tradeNames_string) LIKE "%pr... | [{'UUID': 'DrugGeneTargets_v2_5936', 'drugName': 'Prednisolone Phosphoric Acid', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NR3C1 (ENSG00000113580)', 'yearOfFirstApproval': 1973, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1227 | Q59 | What is the genetic target of the small molecule drug Neostigmine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Neostigmine is ACHE. Neostigmine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%neostigmine%" OR LOWER(tradeNames_string) LIKE "%neostigmine%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_6228', 'drugName': 'Neostigmine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ACHE (ENSG00000087085)', 'yearOfFirstApproval': 2013, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1766', 'drugName': 'Neostigmine Methylsulfate', 'drug... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1434 | Q59 | What is the genetic target of the small molecule drug Enobosarm, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Enobosarm is AR. Enobosarm reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%enobosarm%" OR LOWER(tradeNames_string) LIKE "%enobosarm%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_1611', 'drugName': 'Enobosarm', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'AR (ENSG00000169083)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1954 | Q59 | What is the genetic target of the small molecule drug Minopafant, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Minopafant is PTAFR. Minopafant reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%minopafant%" OR LOWER(tradeNames_string) LIKE "%minopafant%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2350', 'drugName': 'Minopafant', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTAFR (ENSG00000169403)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.954 | Q59 | What is the genetic target of the small molecule drug Hydroxyprogesterone Caproate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Hydroxyprogesterone Caproate is PGR. Hydroxyprogesterone Caproate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%hydroxyprogesterone caproate%" OR LOWER(tradeNames_string) LIKE "%hy... | [{'UUID': 'DrugGeneTargets_v2_4832', 'drugName': 'Hydroxyprogesterone Caproate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PGR (ENSG00000082175)', 'yearOfFirstApproval': 1975, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.172 | Q59 | What is the genetic target of the small molecule drug Brimonidine Tartrate, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Brimonidine Tartrate: ADRA2A, ADRA2C, and ADRA2B. Brimonidine Tartrate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%brimonidine tartrate%" OR LOWER(tradeNames_string) LIKE "%brimonidin... | [{'UUID': 'DrugGeneTargets_v2_4923', 'drugName': 'Brimonidine Tartrate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA2A (ENSG00000150594), ADRA2C (ENSG00000184160), ADRA2B (ENSG00000274286)', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1406 | Q59 | What is the genetic target of the small molecule drug Ly2881835, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ly2881835 is FFAR1. Ly2881835 reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ly2881835%" OR LOWER(tradeNames_string) LIKE "%ly2881835%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_5831', 'drugName': 'Ly2881835', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'FFAR1 (ENSG00000126266)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1207 | Q59 | What is the genetic target of the small molecule drug Perhexiline, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Perhexiline: MTOR, CPT2, and CPT1B. Perhexiline reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%perhexiline%" OR LOWER(tradeNames_string) LIKE "%perhexiline%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_1726', 'drugName': 'Perhexiline Maleate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MTOR (ENSG00000198793), CPT2 (ENSG00000157184), CPT1B (ENSG00000205560)', 'yearOfFirstApproval': 1974, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1263 | Q59 | What is the genetic target of the small molecule drug Moxisylyte, and what is its status in clinical trials and FDA approval? | There are 6 genetic targets of the small molecule drug Moxisylyte: ADRA1A, ADRA2A, ADRA2C, ADRA1D, ADRA1B, and ADRA2B. Moxisylyte reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%moxisylyte%" OR LOWER(tradeNames_string) LIKE "%moxisylyte%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_770', 'drugName': 'Moxisylyte', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907), ADRA2A (ENSG00000150594), ADRA2C (ENSG00000184160), ADRA1D (ENSG00000171873), ADRA1B (ENSG00000170214), ADRA2B (ENSG00000274286)', 'yearOfFirstApproval': 0, 'maxClin... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1400 | Q59 | What is the genetic target of the small molecule drug Febuxostat, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Febuxostat is XDH. Febuxostat reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%febuxostat%" OR LOWER(tradeNames_string) LIKE "%febuxostat%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_1230', 'drugName': 'Febuxostat', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'XDH (ENSG00000158125)', 'yearOfFirstApproval': 2009, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.920 | Q59 | What is the genetic target of the small molecule drug Leq506, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Leq506 is SMO. Leq506 reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%leq506%" OR LOWER(tradeNames_string) LIKE "%leq506%" OR LOWER(drugSy... | [{'UUID': 'DrugGeneTargets_v2_688', 'drugName': 'Leq506', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SMO (ENSG00000128602)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.497 | Q59 | What is the genetic target of the antibody drug Spesolimab, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the antibody drug Spesolimab: IL1RL2 and IL1RAP. Spesolimab reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%spesolimab%" OR LOWER(tradeNames_string) LIKE "%spesolimab%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2421', 'drugName': 'Spesolimab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'IL1RL2 (ENSG00000115598), IL1RAP (ENSG00000196083)', 'yearOfFirstApproval': 2022, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.962 | Q59 | What is the genetic target of the small molecule drug Ethacrynic Acid, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ethacrynic Acid is SLC12A1. Ethacrynic Acid reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ethacrynic acid%" OR LOWER(tradeNames_string) LIKE "%ethacrynic acid... | [{'UUID': 'DrugGeneTargets_v2_3791', 'drugName': 'Ethacrynic Acid', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC12A1 (ENSG00000074803)', 'yearOfFirstApproval': 1967, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3044', 'drugName': 'Ethacrynate Sodium', 'drug... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1106 | Q59 | What is the genetic target of the small molecule drug Spirapril, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Spirapril is ACE. Spirapril reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%spirapril%" OR LOWER(tradeNames_string) LIKE "%spirapril%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_2773', 'drugName': 'Spirapril', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ACE (ENSG00000159640)', 'yearOfFirstApproval': 1994, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4466', 'drugName': 'Spirapril Hydrochloride', 'drugMolec... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1041 | Q59 | What is the genetic target of the small molecule drug Glyburide, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Glyburide: KCNJ11 and ABCC8. Glyburide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%glyburide%" OR LOWER(tradeNames_string) LIKE "%glyburide%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_934', 'drugName': 'Glyburide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'KCNJ11 (ENSG00000187486), ABCC8 (ENSG00000006071)', 'yearOfFirstApproval': 1984, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.594 | Q59 | What is the genetic target of the small molecule drug Lansoprazole, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Lansoprazole: ATP4A and ATP4B. Lansoprazole reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%lansoprazole%" OR LOWER(tradeNames_string) LIKE "%lansoprazole%" OR ... | [{'UUID': 'DrugGeneTargets_v2_2720', 'drugName': 'Lansoprazole', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ATP4A (ENSG00000105675), ATP4B (ENSG00000186009)', 'yearOfFirstApproval': 1995, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_908', 'drugName': 'Dexlans... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.757 | Q59 | What is the genetic target of the protein drug Leuprolide Mesylate, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Leuprolide Mesylate is GNRHR. Leuprolide Mesylate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%leuprolide mesylate%" OR LOWER(tradeNames_string) LIKE "%leuprolide ... | [{'UUID': 'DrugGeneTargets_v2_483', 'drugName': 'Leuprolide Mesylate', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'GNRHR (ENSG00000109163)', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.664 | Q59 | What is the genetic target of the small molecule drug Doxacurium, and what is its status in clinical trials and FDA approval? | There are 5 genetic targets of the small molecule drug Doxacurium: CHRNA1, CHRNG, CHRNB1, CHRND, and CHRNE. Doxacurium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%doxacurium%" OR LOWER(tradeNames_string) LIKE "%doxacurium%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_4981', 'drugName': 'Doxacurium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRNA1 (ENSG00000138435), CHRNG (ENSG00000196811), CHRNB1 (ENSG00000170175), CHRND (ENSG00000135902), CHRNE (ENSG00000108556)', 'yearOfFirstApproval': 1991, 'maxClinicalTrialPhase': 4, 'drug... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.237 | Q59 | What is the genetic target of the small molecule drug Tetrahydrozoline Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 6 genetic targets of the small molecule drug Tetrahydrozoline Hydrochloride: ADRA1A, ADRA2A, ADRA2C, ADRA1D, ADRA1B, and ADRA2B. Tetrahydrozoline Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tetrahydrozoline hydrochloride%" OR LOWER(tradeNames_string) LIKE "%... | [{'UUID': 'DrugGeneTargets_v2_1295', 'drugName': 'Tetrahydrozoline Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907), ADRA2A (ENSG00000150594), ADRA2C (ENSG00000184160), ADRA1D (ENSG00000171873), ADRA1B (ENSG00000170214), ADRA2B (ENSG00000274286)', 'yearOfFirstA... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.739 | Q59 | What is the genetic target of the small molecule drug Pindolol, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Pindolol: ADRB1 and ADRB2. Pindolol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pindolol%" OR LOWER(tradeNames_string) LIKE "%pindolol%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_4457', 'drugName': 'Pindolol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRB1 (ENSG00000043591), ADRB2 (ENSG00000169252)', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4458', 'drugName': 'Pindolol',... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1989 | Q59 | What is the genetic target of the small molecule drug Methyltestosterone, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Methyltestosterone is AR. Methyltestosterone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%methyltestosterone%" OR LOWER(tradeNames_string) LIKE "%methyltestos... | [{'UUID': 'DrugGeneTargets_v2_2216', 'drugName': 'Methyltestosterone', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'AR (ENSG00000169083)', 'yearOfFirstApproval': 1973, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1633 | Q59 | What is the genetic target of the small molecule drug Cangrelor Tetrasodium, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Cangrelor Tetrasodium is P2RY12. Cangrelor Tetrasodium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cangrelor tetrasodium%" OR LOWER(tradeNames_string) LIKE "%cangrelor... | [{'UUID': 'DrugGeneTargets_v2_1075', 'drugName': 'Cangrelor Tetrasodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'P2RY12 (ENSG00000169313)', 'yearOfFirstApproval': 2015, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1166 | Q59 | What is the genetic target of the small molecule drug Mepenzolate, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Mepenzolate: CHRM3 and CHRM1. Mepenzolate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%mepenzolate%" OR LOWER(tradeNames_string) LIKE "%mepenzolate%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3596', 'drugName': 'Mepenzolate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM3 (ENSG00000133019), CHRM1 (ENSG00000168539)', 'yearOfFirstApproval': 1956, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3595', 'drugName': 'Mepenzo... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1471 | Q59 | What is the genetic target of the antibody drug Gevokizumab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Gevokizumab is IL1B. Gevokizumab reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%gevokizumab%" OR LOWER(tradeNames_string) LIKE "%gevokizumab%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_4946', 'drugName': 'Gevokizumab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'IL1B (ENSG00000125538)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1913 | Q59 | What is the genetic target of the small molecule drug Ivabradine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ivabradine is HCN4. Ivabradine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ivabradine%" OR LOWER(tradeNames_string) LIKE "%ivabradine%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_32', 'drugName': 'Ivabradine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HCN4 (ENSG00000138622)', 'yearOfFirstApproval': 2015, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1183', 'drugName': 'Ivabradine Hydrochloride', 'drugMole... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1628 | Q59 | What is the genetic target of the small molecule drug Merimepodib, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Merimepodib is IMPDH1. Merimepodib reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%merimepodib%" OR LOWER(tradeNames_string) LIKE "%merimepodib%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_4814', 'drugName': 'Merimepodib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'IMPDH1 (ENSG00000106348)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.943 | Q59 | What is the genetic target of the protein drug Bulevirtide, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Bulevirtide is SLC10A1. Bulevirtide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%bulevirtide%" OR LOWER(tradeNames_string) LIKE "%bulevirtide%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_1428', 'drugName': 'Bulevirtide', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'SLC10A1 (ENSG00000100652)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1219 | Q59 | What is the genetic target of the small molecule drug Ospemifene, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Ospemifene: ESR2 and ESR1. Ospemifene reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ospemifene%" OR LOWER(tradeNames_string) LIKE "%ospemifene%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_3057', 'drugName': 'Ospemifene', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ESR2 (ENSG00000140009), ESR1 (ENSG00000091831)', 'yearOfFirstApproval': 2013, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1074 | Q59 | What is the genetic target of the small molecule drug Zucapsaicin, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Zucapsaicin is TRPV1. Zucapsaicin reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%zucapsaicin%" OR LOWER(tradeNames_string) LIKE "%zucapsaicin%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_366', 'drugName': 'Zucapsaicin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TRPV1 (ENSG00000196689)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.111 | Q59 | What is the genetic target of the small molecule drug Methsuximide, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Methsuximide: CACNA1H, CACNA1G, and CACNA1I. Methsuximide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%methsuximide%" OR LOWER(tradeNames_string) LIKE "%methsuximide%" OR ... | [{'UUID': 'DrugGeneTargets_v2_4085', 'drugName': 'Methsuximide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CACNA1H (ENSG00000196557), CACNA1G (ENSG00000006283), CACNA1I (ENSG00000100346)', 'yearOfFirstApproval': 1957, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1944 | Q59 | What is the genetic target of the oligonucleotide drug Tofersen, and what is its status in clinical trials and FDA approval? | The genetic target of the oligonucleotide drug Tofersen is SOD1. Tofersen reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tofersen%" OR LOWER(tradeNames_string) LIKE "%tofersen%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_651', 'drugName': 'Tofersen', 'drugMolecularType': 'Oligonucleotide', 'newLinkedTargets_string': 'SOD1 (ENSG00000142168)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.574 | Q59 | What is the genetic target of the small molecule drug Ergocalciferol, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ergocalciferol is VDR. Ergocalciferol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ergocalciferol%" OR LOWER(tradeNames_string) LIKE "%ergocalciferol%"... | [{'UUID': 'DrugGeneTargets_v2_356', 'drugName': 'Ergocalciferol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'VDR (ENSG00000111424)', 'yearOfFirstApproval': 1941, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4241', 'drugName': 'Doxercalciferol', 'drugMolecular... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1177 | Q59 | What is the genetic target of the small molecule drug Mk-1029, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Mk-1029 is PTGDR2. Mk-1029 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%mk-1029%" OR LOWER(tradeNames_string) LIKE "%mk-1029%" OR LOWER(drug... | [{'UUID': 'DrugGeneTargets_v2_6289', 'drugName': 'Mk-1029', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGDR2 (ENSG00000183134)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1184 | Q59 | What is the genetic target of the small molecule drug Tepotinib, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Tepotinib is MET. Tepotinib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tepotinib%" OR LOWER(tradeNames_string) LIKE "%tepotinib%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_1379', 'drugName': 'Tepotinib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MET (ENSG00000105976)', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1908', 'drugName': 'Tepotinib Hydrochloride', 'drugMolec... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.897 | Q59 | What is the genetic target of the small molecule drug Masitinib, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Masitinib: KIT, PDGFRB, PDGFRA, and FGFR3. Masitinib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%masitinib%" OR LOWER(tradeNames_string) LIKE "%masitinib%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_4752', 'drugName': 'Masitinib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'KIT (ENSG00000157404), PDGFRB (ENSG00000113721), PDGFRA (ENSG00000134853), FGFR3 (ENSG00000068078)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'D... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.956 | Q59 | What is the genetic target of the small molecule drug Imatinib Mesylate, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Imatinib Mesylate: ABL1, PDGFRB, KIT, and BCR. Imatinib Mesylate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%imatinib mesylate%" OR LOWER(tradeNames_string) LIKE "%imatinib mesy... | [{'UUID': 'DrugGeneTargets_v2_3270', 'drugName': 'Imatinib Mesylate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ABL1 (ENSG00000097007), PDGFRB (ENSG00000113721), KIT (ENSG00000157404), BCR (ENSG00000186716)', 'yearOfFirstApproval': 2001, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UU... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1057 | Q59 | What is the genetic target of the antibody drug Rg-7652, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Rg-7652 is PCSK9. Rg-7652 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%rg-7652%" OR LOWER(tradeNames_string) LIKE "%rg-7652%" OR LOWER(drug... | [{'UUID': 'DrugGeneTargets_v2_1023', 'drugName': 'Rg-7652', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'PCSK9 (ENSG00000169174)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1354 | Q59 | What is the genetic target of the small molecule drug Paroxetine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Paroxetine is SLC6A4. Paroxetine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%paroxetine%" OR LOWER(tradeNames_string) LIKE "%paroxetine%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_4720', 'drugName': 'Paroxetine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A4 (ENSG00000108576)', 'yearOfFirstApproval': 1992, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5200', 'drugName': 'Paroxetine', 'drug... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1373 | Q59 | What is the genetic target of the small molecule drug Sonidegib, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Sonidegib is SMO. Sonidegib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%sonidegib%" OR LOWER(tradeNames_string) LIKE "%sonidegib%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_3128', 'drugName': 'Sonidegib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SMO (ENSG00000128602)', 'yearOfFirstApproval': 2015, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3933', 'drugName': 'Sonidegib Phosphate', 'drugMolecular... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1448 | Q59 | What is the genetic target of the small molecule drug Imarikiren Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Imarikiren Hydrochloride is REN. Imarikiren Hydrochloride reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%imarikiren hydrochloride%" OR LOWER(tradeNames_string) LIKE "%imarik... | [{'UUID': 'DrugGeneTargets_v2_3903', 'drugName': 'Imarikiren Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'REN (ENSG00000143839)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.891 | Q59 | What is the genetic target of the small molecule drug Orvepitant, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Orvepitant is TACR1. Orvepitant reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%orvepitant%" OR LOWER(tradeNames_string) LIKE "%orvepitant%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2045', 'drugName': 'Orvepitant', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TACR1 (ENSG00000115353)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1673 | Q59 | What is the genetic target of the small molecule drug Verubecestat, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Verubecestat is BACE1. Verubecestat reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%verubecestat%" OR LOWER(tradeNames_string) LIKE "%verubecestat%" OR ... | [{'UUID': 'DrugGeneTargets_v2_724', 'drugName': 'Verubecestat', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'BACE1 (ENSG00000186318)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.857 | Q59 | What is the genetic target of the small molecule drug Ave0847, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Ave0847: PPARD and PPARG. Ave0847 reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ave0847%" OR LOWER(tradeNames_string) LIKE "%ave0847%" OR LOWER(drug... | [{'UUID': 'DrugGeneTargets_v2_729', 'drugName': 'Ave0847', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PPARD (ENSG00000112033), PPARG (ENSG00000132170)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_730', 'drugName': 'Ave0847', 'drug... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.741 | Q59 | What is the genetic target of the small molecule drug Ziprasidone, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Ziprasidone: HTR2A, DRD2, and HTR2C. Ziprasidone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ziprasidone%" OR LOWER(tradeNames_string) LIKE "%ziprasidone%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_1685', 'drugName': 'Ziprasidone', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HTR2A (ENSG00000102468), DRD2 (ENSG00000149295), HTR2C (ENSG00000147246)', 'yearOfFirstApproval': 2001, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_428... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.724 | Q59 | What is the genetic target of the antibody drug Quetmolimab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Quetmolimab is CX3CL1. Quetmolimab reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%quetmolimab%" OR LOWER(tradeNames_string) LIKE "%quetmolimab%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_537', 'drugName': 'Quetmolimab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'CX3CL1 (ENSG00000006210)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.460 | Q59 | What is the genetic target of the small molecule drug Tetracaine, and what is its status in clinical trials and FDA approval? | There are 10 genetic targets of the small molecule drug Tetracaine: SCN1A, SCN5A, SCN4A, SCN7A, SCN2A, SCN9A, SCN3A, SCN11A, SCN8A, and SCN10A. Tetracaine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tetracaine%" OR LOWER(tradeNames_string) LIKE "%tetracaine%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_5460', 'drugName': 'Tetracaine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SCN1A (ENSG00000144285), SCN5A (ENSG00000183873), SCN4A (ENSG00000007314), SCN7A (ENSG00000136546), SCN2A (ENSG00000136531), SCN9A (ENSG00000169432), SCN3A (ENSG00000153253), SCN11A (ENSG000... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.267 | Q59 | What is the genetic target of the small molecule drug Lisdexamfetamine Dimesylate, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Lisdexamfetamine Dimesylate: SLC18A2, SLC6A2, and SLC6A3. Lisdexamfetamine Dimesylate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%lisdexamfetamine dimesylate%" OR LOWER(tradeNames_string) LIKE "%lis... | [{'UUID': 'DrugGeneTargets_v2_2130', 'drugName': 'Lisdexamfetamine Dimesylate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC18A2 (ENSG00000165646), SLC6A2 (ENSG00000103546), SLC6A3 (ENSG00000142319)', 'yearOfFirstApproval': 2007, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'D... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.78 | Q59 | What is the genetic target of the protein drug Pasireotide Diaspartate, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the protein drug Pasireotide Diaspartate: SSTR3, SSTR2, SSTR1, and SSTR5. Pasireotide Diaspartate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pasireotide diaspartate%" OR LOWER(tradeNames_string) LIKE "%pasireo... | [{'UUID': 'DrugGeneTargets_v2_1407', 'drugName': 'Pasireotide Diaspartate', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'SSTR3 (ENSG00000278195), SSTR2 (ENSG00000180616), SSTR1 (ENSG00000139874), SSTR5 (ENSG00000162009)', 'yearOfFirstApproval': 2012, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1785 | Q59 | What is the genetic target of the small molecule drug Barasertib, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Barasertib is AURKB. Barasertib reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%barasertib%" OR LOWER(tradeNames_string) LIKE "%barasertib%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_3821', 'drugName': 'Barasertib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'AURKB (ENSG00000178999)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.450 | Q59 | What is the genetic target of the small molecule drug Mefenamic Acid, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Mefenamic Acid: PTGS2 and PTGS1. Mefenamic Acid reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%mefenamic acid%" OR LOWER(tradeNames_string) LIKE "%mefenamic acid%"... | [{'UUID': 'DrugGeneTargets_v2_4888', 'drugName': 'Mefenamic Acid', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756), PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 1967, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.401 | Q59 | What is the genetic target of the small molecule drug Cortivazol, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Cortivazol is NR3C1. Cortivazol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cortivazol%" OR LOWER(tradeNames_string) LIKE "%cortivazol%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2892', 'drugName': 'Cortivazol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NR3C1 (ENSG00000113580)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.179 | Q59 | What is the genetic target of the small molecule drug Mephenytoin, and what is its status in clinical trials and FDA approval? | There are 10 genetic targets of the small molecule drug Mephenytoin: SCN1A, SCN5A, SCN4A, SCN7A, SCN2A, SCN9A, SCN3A, SCN11A, SCN8A, and SCN10A. Mephenytoin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%mephenytoin%" OR LOWER(tradeNames_string) LIKE "%mephenytoin%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5011', 'drugName': 'Mephenytoin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SCN1A (ENSG00000144285), SCN5A (ENSG00000183873), SCN4A (ENSG00000007314), SCN7A (ENSG00000136546), SCN2A (ENSG00000136531), SCN9A (ENSG00000169432), SCN3A (ENSG00000153253), SCN11A (ENSG00... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1051 | Q59 | What is the genetic target of the small molecule drug Prenylamine, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Prenylamine: SCN5A and CALM1. Prenylamine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%prenylamine%" OR LOWER(tradeNames_string) LIKE "%prenylamine%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5448', 'drugName': 'Prenylamine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SCN5A (ENSG00000183873), CALM1 (ENSG00000198668)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5449', 'drugName': 'Prenylamin... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1737 | Q59 | What is the genetic target of the small molecule drug Azd-1656, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Azd-1656 is GCK. Azd-1656 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%azd-1656%" OR LOWER(tradeNames_string) LIKE "%azd-1656%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_1410', 'drugName': 'Azd-1656', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'GCK (ENSG00000106633)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1609 | Q59 | What is the genetic target of the small molecule drug Proparacaine Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 10 genetic targets of the small molecule drug Proparacaine Hydrochloride: SCN1A, SCN5A, SCN4A, SCN7A, SCN2A, SCN9A, SCN3A, SCN11A, SCN8A, and SCN10A. Proparacaine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%proparacaine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%prop... | [{'UUID': 'DrugGeneTargets_v2_2948', 'drugName': 'Proparacaine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SCN1A (ENSG00000144285), SCN5A (ENSG00000183873), SCN4A (ENSG00000007314), SCN7A (ENSG00000136546), SCN2A (ENSG00000136531), SCN9A (ENSG00000169432), SCN3A (ENSG00000153253),... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1869 | Q59 | What is the genetic target of the protein drug Svn53-67/M57-Klh Peptide Vaccine, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Svn53-67/M57-Klh Peptide Vaccine is BIRC5. Svn53-67/M57-Klh Peptide Vaccine reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%svn53-67/m57-klh peptide vaccine%" OR LOWER(tradeNames_string) LIKE ... | [{'UUID': 'DrugGeneTargets_v2_3713', 'drugName': 'Svn53-67/M57-Klh Peptide Vaccine', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'BIRC5 (ENSG00000089685)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_3714', 'drugName': 'Svn53-67/M57-Klh Pep... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.602 | Q59 | What is the genetic target of the small molecule drug Fedratinib Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Fedratinib Hydrochloride: JAK2 and FLT3. Fedratinib Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fedratinib hydrochloride%" OR LOWER(tradeNames_string) LIKE "%fedrat... | [{'UUID': 'DrugGeneTargets_v2_4654', 'drugName': 'Fedratinib Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'JAK2 (ENSG00000096968), FLT3 (ENSG00000122025)', 'yearOfFirstApproval': 2019, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4655', 'drugName... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.63 | Q59 | What is the genetic target of the small molecule drug Pelitrexol, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Pelitrexol is GART. Pelitrexol reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pelitrexol%" OR LOWER(tradeNames_string) LIKE "%pelitrexol%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2859', 'drugName': 'Pelitrexol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'GART (ENSG00000159131)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1309 | Q59 | What is the genetic target of the small molecule drug Allopurinol, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Allopurinol is XDH. Allopurinol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%allopurinol%" OR LOWER(tradeNames_string) LIKE "%allopurinol%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5751', 'drugName': 'Allopurinol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'XDH (ENSG00000158125)', 'yearOfFirstApproval': 1966, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3457', 'drugName': 'Allopurinol Sodium', 'drugMolecula... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.879 | Q59 | What is the genetic target of the small molecule drug Diphenhydramine Citrate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Diphenhydramine Citrate is HRH1. Diphenhydramine Citrate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%diphenhydramine citrate%" OR LOWER(tradeNames_string) LIKE "%diphenh... | [{'UUID': 'DrugGeneTargets_v2_613', 'drugName': 'Diphenhydramine Citrate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 2005, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1491 | Q59 | What is the genetic target of the small molecule drug Phenytoin Sodium, and what is its status in clinical trials and FDA approval? | There are 10 genetic targets of the small molecule drug Phenytoin Sodium: SCN1A, SCN5A, SCN4A, SCN7A, SCN2A, SCN9A, SCN3A, SCN11A, SCN8A, and SCN10A. Phenytoin Sodium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%phenytoin sodium%" OR LOWER(tradeNames_string) LIKE "%phenytoin sodi... | [{'UUID': 'DrugGeneTargets_v2_1082', 'drugName': 'Phenytoin Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SCN1A (ENSG00000144285), SCN5A (ENSG00000183873), SCN4A (ENSG00000007314), SCN7A (ENSG00000136546), SCN2A (ENSG00000136531), SCN9A (ENSG00000169432), SCN3A (ENSG00000153253), SCN11A (E... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1880 | Q59 | What is the genetic target of the small molecule drug Suxamethonium, and what is its status in clinical trials and FDA approval? | There are 5 genetic targets of the small molecule drug Suxamethonium: CHRNA1, CHRNG, CHRNB1, CHRND, and CHRNE. Suxamethonium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%suxamethonium%" OR LOWER(tradeNames_string) LIKE "%suxamethonium%" O... | [{'UUID': 'DrugGeneTargets_v2_6206', 'drugName': 'Suxamethonium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRNA1 (ENSG00000138435), CHRNG (ENSG00000196811), CHRNB1 (ENSG00000170175), CHRND (ENSG00000135902), CHRNE (ENSG00000108556)', 'yearOfFirstApproval': 1952, 'maxClinicalTrialPhase': 4, 'd... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.282 | Q59 | What is the genetic target of the protein drug Semaglutide, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Semaglutide is GLP1R. Semaglutide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%semaglutide%" OR LOWER(tradeNames_string) LIKE "%semaglutide%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_6086', 'drugName': 'Semaglutide', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'GLP1R (ENSG00000112164)', 'yearOfFirstApproval': 2017, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.37 | Q59 | What is the genetic target of the small molecule drug Azd-8848, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Azd-8848 is TLR7. Azd-8848 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%azd-8848%" OR LOWER(tradeNames_string) LIKE "%azd-8848%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_3550', 'drugName': 'Azd-8848', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TLR7 (ENSG00000196664)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1517 | Q59 | What is the genetic target of the protein drug Gonadorelin Acetate, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Gonadorelin Acetate is GNRHR. Gonadorelin Acetate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%gonadorelin acetate%" OR LOWER(tradeNames_string) LIKE "%gonadorelin... | [{'UUID': 'DrugGeneTargets_v2_3355', 'drugName': 'Gonadorelin Acetate', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'GNRHR (ENSG00000109163)', 'yearOfFirstApproval': 1989, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.669 | Q59 | What is the genetic target of the small molecule drug Medroxyprogesterone Acetate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Medroxyprogesterone Acetate is PGR. Medroxyprogesterone Acetate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%medroxyprogesterone acetate%" OR LOWER(tradeNames_string) LIKE "%med... | [{'UUID': 'DrugGeneTargets_v2_2722', 'drugName': 'Medroxyprogesterone Acetate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PGR (ENSG00000082175)', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1829 | Q59 | What is the genetic target of the small molecule drug Phenazopyridine Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 10 genetic targets of the small molecule drug Phenazopyridine Hydrochloride: SCN1A, SCN5A, SCN4A, SCN7A, SCN2A, SCN9A, SCN3A, SCN11A, SCN8A, and SCN10A. Phenazopyridine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%phenazopyridine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%p... | [{'UUID': 'DrugGeneTargets_v2_1016', 'drugName': 'Phenazopyridine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SCN1A (ENSG00000144285), SCN5A (ENSG00000183873), SCN4A (ENSG00000007314), SCN7A (ENSG00000136546), SCN2A (ENSG00000136531), SCN9A (ENSG00000169432), SCN3A (ENSG0000015325... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1446 | Q59 | What is the genetic target of the small molecule drug Indoprofen, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Indoprofen: PTGS2 and PTGS1. Indoprofen reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%indoprofen%" OR LOWER(tradeNames_string) LIKE "%indoprofen%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_4357', 'drugName': 'Indoprofen', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756), PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 1979, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.986 | Q59 | What is the genetic target of the small molecule drug Siponimod, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Siponimod is S1PR1. Siponimod reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%siponimod%" OR LOWER(tradeNames_string) LIKE "%siponimod%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_4451', 'drugName': 'Siponimod Fumarate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'S1PR1 (ENSG00000170989)', 'yearOfFirstApproval': 2019, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_265', 'drugName': 'Siponimod', 'drugMolecular... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1572 | Q59 | What is the genetic target of the protein drug Brimapitide, C-Terminal Acid, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Brimapitide, C-Terminal Acid is MAPK10. Brimapitide, C-Terminal Acid reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%brimapitide, c-terminal acid%" OR LOWER(tradeNames_string) LIKE "%br... | [{'UUID': 'DrugGeneTargets_v2_504', 'drugName': 'Brimapitide, C-Terminal Acid', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'MAPK10 (ENSG00000109339)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.745 | Q59 | What is the genetic target of the oligonucleotide drug Nusinersen, and what is its status in clinical trials and FDA approval? | The genetic target of the oligonucleotide drug Nusinersen is SMN2. Nusinersen reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%nusinersen%" OR LOWER(tradeNames_string) LIKE "%nusinersen%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2674', 'drugName': 'Nusinersen', 'drugMolecularType': 'Oligonucleotide', 'newLinkedTargets_string': 'SMN2 (ENSG00000205571)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6328', 'drugName': 'Nusinersen Sodium', 'drugMolecularTy... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.194 | Q59 | What is the genetic target of the small molecule drug Dacomitinib, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Dacomitinib: ERBB4, ERBB2, and EGFR. Dacomitinib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dacomitinib%" OR LOWER(tradeNames_string) LIKE "%dacomitinib%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3948', 'drugName': 'Dacomitinib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ERBB4 (ENSG00000178568), ERBB2 (ENSG00000141736), EGFR (ENSG00000146648)', 'yearOfFirstApproval': 2018, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_481... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.927 | Q59 | What is the genetic target of the small molecule drug Guanadrel, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Guanadrel is SLC6A2. Guanadrel reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%guanadrel%" OR LOWER(tradeNames_string) LIKE "%guanadrel%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_380', 'drugName': 'Guanadrel', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A2 (ENSG00000103546)', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2355', 'drugName': 'Guanadrel Sulfate', 'drugMolecular... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.462 | Q59 | What is the genetic target of the small molecule drug Azelastine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Azelastine is HRH1. Azelastine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%azelastine%" OR LOWER(tradeNames_string) LIKE "%azelastine%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_3567', 'drugName': 'Azelastine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2721', 'drugName': 'Azelastine', 'drugMo... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.682 | Q59 | What is the genetic target of the small molecule drug Rauwolfia Serpentina, and what is its status in clinical trials and FDA approval? | There are 6 genetic targets of the small molecule drug Rauwolfia Serpentina: ADRA1A, ADRA2A, ADRA2C, ADRA1D, ADRA1B, and ADRA2B. Rauwolfia Serpentina reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%rauwolfia serpentina%" OR LOWER(tradeNames_string) LIKE "%rauwolfia ... | [{'UUID': 'DrugGeneTargets_v2_4856', 'drugName': 'Rauwolfia Serpentina', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907), ADRA2A (ENSG00000150594), ADRA2C (ENSG00000184160), ADRA1D (ENSG00000171873), ADRA1B (ENSG00000170214), ADRA2B (ENSG00000274286)', 'yearOfFirstApproval': ... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.767 | Q59 | What is the genetic target of the small molecule drug Arry-797, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Arry-797 is MAPK14. Arry-797 reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%arry-797%" OR LOWER(tradeNames_string) LIKE "%arry-797%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_319', 'drugName': 'Arry-797', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MAPK14 (ENSG00000112062)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1809 | Q59 | What is the genetic target of the small molecule drug Dinoprostone, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Dinoprostone: PTGER1, PTGER4, PTGER2, and PTGER3. Dinoprostone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dinoprostone%" OR LOWER(tradeNames_string) LIKE "%dinoprostone%" OR ... | [{'UUID': 'DrugGeneTargets_v2_4965', 'drugName': 'Dinoprostone', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGER1 (ENSG00000160951), PTGER4 (ENSG00000171522), PTGER2 (ENSG00000125384), PTGER3 (ENSG00000050628)', 'yearOfFirstApproval': 1977, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1603 | Q59 | What is the genetic target of the antibody drug Camoteskimab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Camoteskimab is IL18. Camoteskimab reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%camoteskimab%" OR LOWER(tradeNames_string) LIKE "%camoteskimab%" OR ... | [{'UUID': 'DrugGeneTargets_v2_6087', 'drugName': 'Camoteskimab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'IL18 (ENSG00000150782)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.735 | Q59 | What is the genetic target of the small molecule drug Phenylephrine Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Phenylephrine Hydrochloride: ADRA1A, ADRA1D, and ADRA1B. Phenylephrine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%phenylephrine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%phe... | [{'UUID': 'DrugGeneTargets_v2_3941', 'drugName': 'Phenylephrine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907), ADRA1D (ENSG00000171873), ADRA1B (ENSG00000170214)', 'yearOfFirstApproval': 1952, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.418 | Q59 | What is the genetic target of the small molecule drug Ponesimod, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ponesimod is S1PR1. Ponesimod reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ponesimod%" OR LOWER(tradeNames_string) LIKE "%ponesimod%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_3600', 'drugName': 'Ponesimod', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'S1PR1 (ENSG00000170989)', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1107 | Q59 | What is the genetic target of the small molecule drug Proxibarbal, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Proxibarbal: AOC1 and MAOA. Proxibarbal reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%proxibarbal%" OR LOWER(tradeNames_string) LIKE "%proxibarbal%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_472', 'drugName': 'Proxibarbal', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'AOC1 (ENSG00000002726), MAOA (ENSG00000189221)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_473', 'drugName': 'Proxibarbal', ... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.832 | Q59 | What is the genetic target of the small molecule drug Rizatriptan, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Rizatriptan: HTR1D and HTR1B. Rizatriptan reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%rizatriptan%" OR LOWER(tradeNames_string) LIKE "%rizatriptan%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_1141', 'drugName': 'Rizatriptan Benzoate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HTR1D (ENSG00000179546), HTR1B (ENSG00000135312)', 'yearOfFirstApproval': 1998, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1140', 'drugName':... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1498 | Q59 | What is the genetic target of the small molecule drug Triciribine Phosphate, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Triciribine Phosphate: AKT2, AKT3, and AKT1. Triciribine Phosphate reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%triciribine phosphate%" OR LOWER(tradeNames_string) LIKE "%triciribi... | [{'UUID': 'DrugGeneTargets_v2_511', 'drugName': 'Triciribine Phosphate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'AKT2 (ENSG00000105221), AKT3 (ENSG00000117020), AKT1 (ENSG00000142208)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.623 | Q59 | What is the genetic target of the small molecule drug Oxtriphylline, and what is its status in clinical trials and FDA approval? | There are 10 genetic targets of the small molecule drug Oxtriphylline: PDE3A, PDE3B, PDE4A, PDE4D, PDE4B, PDE4C, ADORA1, ADORA2B, ADORA3, and ADORA2A. Oxtriphylline reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%oxtriphylline%" OR LOWER(tradeNames_string) LIKE "%oxtriphylline%" O... | [{'UUID': 'DrugGeneTargets_v2_3797', 'drugName': 'Oxtriphylline', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PDE3A (ENSG00000172572), PDE3B (ENSG00000152270), PDE4A (ENSG00000065989), PDE4D (ENSG00000113448), PDE4B (ENSG00000184588), PDE4C (ENSG00000105650), ADORA1 (ENSG00000163485), ADORA2B (EN... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.